Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197586 Use of secretin and optionally urodilatin as therapeutic agents
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197567 Conus polypeptides
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196510 Composition and treatment
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196486 Methods for producing aripiprazole suspension and freeze-dried formulation
08/05/2010US20100196475 Controlled release tablet formulation containing magnesium aluminometasilicate
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196471 Novel tablet dosage form
08/05/2010US20100196463 Methods and compositions for reduction of side effects of therapeutic treatments
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196457 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
08/05/2010US20100196449 System and method to improve sensory function
08/05/2010US20100196436 Implants containing disulfiram and an anti-inflammatory agent
08/05/2010US20100196404 Methods of use of the taci/taci-l interaction
08/05/2010US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196351 Secreted pate-like proteins
08/05/2010US20100196349 Reeler domain containing protein
08/05/2010US20100196342 Mood, memory and cognitive function with pyridoxal 5'-phosphate
08/05/2010US20100196328 ISCHEMIA-INDUCED NEOVASCULARIZATION IS ENHANCED BY hCNS-SC TRANSPLANTATION
08/05/2010US20100196326 Method and system for biasing cellular development
08/05/2010US20100196317 Cyclic undecapeptides and derivatives as multiple sclerosis therapies
08/05/2010US20100196286 Inhalation delivery methods and devices
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010US20100192945 Inhalation devices and related methods for administration of sedative hypnotic compounds
08/05/2010CA2751285A1 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
08/05/2010CA2751275A1 Methods for improving cognitive function and decreasing heart rate
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2751176A1 Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/05/2010CA2751125A1 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010CA2751037A1 Drug abuse deterrent, methods and compositions
08/05/2010CA2751033A1 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/05/2010CA2747961A1 Piperidine derivatives as nk3 receptor antagonists
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213684A2 Nogo-a antibodies for the treatment of Alzheimer disease
08/04/2010EP2213290A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/04/2010EP2213285A2 Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
08/04/2010EP2212322A1 Quinolizidinone m1 receptor positive allosteric modulators
08/04/2010EP2212321A2 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212309A1 Trisubstituted 1,2,4-triazoles
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP2212287A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP2212283A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2212280A1 Amide linked modulators of y-secretase
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/04/2010EP2212246A1 Treatment of neurological disorders
08/04/2010EP2211905A1 Inhibitors of caspase i-dependent cytokines in the treatment of neurodegenerative disorders
08/04/2010EP2211892A2 Composition
08/04/2010EP2211860A1 Combination therapy for reducing side effects using cannabinoid receptor ligands
08/04/2010EP2211850A1 A system and method to improve sensory function
08/04/2010EP2211847A1 Controlled-release pharmaceutical formulation
08/04/2010EP2211760A1 Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems
08/04/2010EP1831201B1 Piperidine and azetidine derivatives as glyt1 inhibitors
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN201536901U Neck pillow capable of placing auxiliary object
08/04/2010CN1915222B Composition of liposome, and preparation method
08/04/2010CN1882352B Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
08/04/2010CN1726911B Controlled release preparation of huperizine
08/04/2010CN101796074A Anti-notch1 NRR antibodies and methods using same
08/04/2010CN101796054A 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands
08/04/2010CN101796053A Piperidine derivatives useful as orexin receptor antagonists
08/04/2010CN101796052A Pyrrolopyridine derivatives and their use as BACE inhibitors
08/04/2010CN101796036A 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators
08/04/2010CN101796034A Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010CN101796018A (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
08/04/2010CN101796017A (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
08/04/2010CN101795727A Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
08/04/2010CN101795710A Oral nicotine formulation buffered with amino acid
08/04/2010CN101795696A Use of hyperbaric conditions to provide neuroprotection
08/04/2010CN101795690A Method for reducing intracranial pressure
08/04/2010CN101795683A Methods for promoting wakefulness
08/04/2010CN101792741A Recombinant baculovirus expressing Japanese Encephalitis Virus (JEV) immunogen gene and preparation method and application thereof
08/04/2010CN101792708A Cinnamon-longan Hakka mother wine, preparation method thereof and application as mind-tranquilizing and digestion-aiding beverage
08/04/2010CN101792485A Alpha-type conus polypeptide and application thereof
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
08/04/2010CN101792415A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/04/2010CN101792399A Aminosalicylic acid derivative lysine complex salt, preparation method and application thereof
08/04/2010CN101791406A Use of sphingosine-1-phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases
08/04/2010CN101791380A Health product for sobering up and relieving alcohol
08/04/2010CN101791360A Health-care tobacco patch
08/04/2010CN101791355A Medicine composition used for preventing birth defects, improving memory and regulating immunity
08/04/2010CN101791354A Medicine composition used for interfering in and preventing birth defects and improving memory
08/04/2010CN101791347A Traditional Chinese medicine preparation for giving up smoking and preparation method thereof
08/04/2010CN101791346A Preparation method of soft capsule for quitting smoking, relieving alcoholism and cleaning oral cavity
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 1833